RSS
21 Feb 2023

Protalix BioTherapeutics to Participate in the 19th Annual WORLDSymposium™ 2023

Author: admintech | Filed under: Press Release

CARMIEL, Israel, Feb. 21, 2023 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant…

This entry was posted on Tuesday, February 21st, 2023 at 7:13 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»